Skip to main content

Colchicine News

FDA Approves Lodoco (colchicine) as the First Anti-Inflammatory Drug for Cardiovascular Disease

Parsippany, NJ – June 20, 2023 – AGEPHA Pharma USA, LLC, today announced that, following a Priority Review, the U.S. Food and Drug Administration (FDA) has approved Lodoco® as the first anti...

FDA Approves Gloperba (colchicine) for Prophylaxis of Adult Gout Flares

WOBURN, Mass.--(BUSINESS WIRE)--February 26, 2019 ROMEG Therapeutics, an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today...

FDA Approves Colcrys (colchicine, USP) for Prevention of Gout Flares

New Colchicine Formulation Significantly Reduces Side Effects, Maintains Full Efficacy; Now Indicated for Both Prophylaxis and Treatment of Gout Flares PHILADELPHIA, Oct. 19 /PRNewswire/ – URL...

FDA Medwatch Alert: Injectable Colchicine (including drugs containing colchicine)

[Posted 02/06/2008] FDA announced its intention to take enforcement action against companies marketing unapproved, injectable colchicine, a drug used to treat gout. Colchicine is a highly toxic drug...

FDA Medwatch Alert: Colchicine Compounded Injectable Products (Posted 05/02/2007)

[Posted 05/02/2007] ApothéCure and FDA notified all healthcare professionals of recent deaths associated with the use of compounded injectable Colchicine 0.5mg/ml, 4ml vials, lot number...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cardiovascular Risk Reduction, Behcet's Disease, Gout - Acute, Constipation - Chronic

Colchicine patient information at Drugs.com